
Alexander Baker
Trial Manager of Addictions
Biography
Alexander joined King's in 2024, currently working as a Trial Manager at the National Addictions Centre at Denmark Hill campus on research involving opioid addiction, clinical trial design and both developing novel therapies and improving the utilisation of existing ones, such as those which rapidly reverse overdose.
As an experienced professional, Alexander has previously worked within industry at a Contract Research Organisation (CRO), leading on national and international clinical trial setup and design, across Phase 1-2 trials.
Graduating from Loughborough University in 2020, after studying a Bachelors in Human Biology with a Diploma in Professional Studies, Alexander went on to study a Masters' of Public Health (Global Health) at the University of Nottingham. Post MPH, he continued with the University to work in academic research within the Migrant Mental Health team, and wider School of Medicine, researching community based interventions utilising patient-public involvement within intervention design, working on art-based therapies for child asylum seekers and migrants based in the UK.
Research Interests
- Epidemiology & global health
- Health policy
- Infectious disease transmission
- Marginalised groups (specifically sexuality & gender)
- Opioid addiction
- Clinical trials and drug development
Alexander is a passionate volunteer, regularly spending free time to volunteer as part of The Scout Association, through which he has been awarded the prestigious 'The King’s Award for Voluntary Service', the highest award given to volunteer groups across the UK. The award is equivalent to an MBE and is awarded for life.
Passionate about the power intersectionality brings to academia, Alexander is involved in IoPPN’s Culture, Equality, Diversity & Inclusion (CEDI) network, keen to drive change to make King’s an inclusive university no matter your background. He is also involved within the Research Management & Admin Network (RMN).
Research

Naloxone
Naloxone is an opiate antagonist which reverses the effects of a heroin overdose.
Project status: Ongoing

Preventing deaths from heroin/opioid overdose: Exploring web-based training in overdose management, naloxone delivery and naloxone carriage.
Research aiming to develop and test ways of increasing the use of naloxone.
Project status: Ongoing

Drugs Research Group
Substance misuse research within the Addictions Department is led by Professors John Strang and John Marsden.
Research

Naloxone
Naloxone is an opiate antagonist which reverses the effects of a heroin overdose.
Project status: Ongoing

Preventing deaths from heroin/opioid overdose: Exploring web-based training in overdose management, naloxone delivery and naloxone carriage.
Research aiming to develop and test ways of increasing the use of naloxone.
Project status: Ongoing

Drugs Research Group
Substance misuse research within the Addictions Department is led by Professors John Strang and John Marsden.